Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Entero Therapeutics ( (ENTO) ).
On July 3, 2025, Entero Therapeutics, Inc. received a notification from Nasdaq confirming that the company has regained compliance with the Nasdaq Listing Rule 5620(a) following its Annual Meeting on June 30, 2025. This resolution closes the compliance matter, potentially stabilizing the company’s market position and reassuring stakeholders of its adherence to regulatory requirements.
More about Entero Therapeutics
Average Trading Volume: 1,255,647
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.89M
Learn more about ENTO stock on TipRanks’ Stock Analysis page.